Novartis Bone Drug Action Doomed By Statute Of Limitations
A New Jersey state judge on Friday dismissed a product liability suit against Novartis Pharmaceuticals Corp. over its bone drug Zometa, citing a recent Virginia Supreme Court decision affirming that claims...To view the full article, register now.
Already a subscriber? Click here to view full article